CLINICAL_TRIALS
trial_result
· 2010-05-26
Clinical Trial Update: Multiepitope Peptide Vaccination in Melanoma [Phase 2]
Summary
A Phase 2 clinical trial evaluating a multiepitope peptide vaccination for metastatic melanoma is ongoing, sponsored by Charité University in Berlin, with curre…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Charite University, Berlin, Germany | Conditions: Metastatic Melanoma | Phase 2 | Status: UNKNOWN